The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques: A Role for Apoptosis in Plaque Thrombogenicity
Abstract
Background —The specific role of apoptosis in human atherosclerosis remains unknown. During apoptotic cell death, phosphatidylserine exposure on the cell surface confers a high tissue-factor (TF)–dependent procoagulant activity. Methods and Results —In this study, we examined the role of apoptotic cell death in the promotion of plaque thrombogenicity. TF expression and its relation to apoptosis was analyzed in 16 human atherosclerotic plaques by the use of immunohistochemical techniques. The presence of shed membrane apoptotic microparticles was analyzed in extracts from 6 human atherosclerotic plaques and 3 underlying arterial walls. The microparticles were captured by annexin V and their amounts estimated with respect to their phospholipid content by use of a prothrombinase assay. The prothrombogenic potential of the microparticles was further assessed by the measurement of total and microparticle-dependent TF activity in the extracts. The cell origin of the microparticles was determined after capture by specific antibodies. We were able to detect marked TF expression in the plaques in close proximity to apoptotic cells and debris, suggesting a potential interaction between TF and the apoptotic cell surfaces. High levels of shed membrane apoptotic microparticles were detected in extracts from atherosclerotic plaques but not in the underlying arterial walls (29.5±3.7 nmol/L phosphatidylserine equivalent versus 1.3±0.4 nmol/L, respectively, P <0.02). The microparticles were mainly of monocytic and lymphocytic origin and retained 97±2% of total TF activity, indicating a direct causal relationship between shed membrane microparticles and procoagulant activity of plaque extracts. Conclusions —These results indicate that shed membrane microparticles with procoagulant potential are produced in human atherosclerotic plaques. Apoptosis could be a critical determinant of plaque thrombogenicity after plaque rupture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., & Green, D. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1545 · Cited by 2,824
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly
Burke, A. P., Farb, A., Malcom, G. T., Liang, Y.-H., Smialek, J., & Virmani, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361802 · Cited by 1,745
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995
Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915
Bennett, M. R., Evan, G. I., & Schwartz, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117917 · Cited by 703
Apoptosis in Human Atherosclerosis and Restenosis
Isner, J. M., Kearney, M., Bortman, S., & Passeri, J. (1995) · Circulation · doi:10.1161/01.cir.91.11.2703 · Cited by 672
Geng, Y., & Libby, P. (1995) · Europe PMC (PubMed Central) · Cited by 640
Apoptotic Vascular Endothelial Cells Become Procoagulant
Bombeli, T., Karsan, A., Tait, J. F., & Harlan, J. M. (1997) · Blood · doi:10.1182/blood.v89.7.2429 · Cited by 622
Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques
Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Ferna´ndez-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.594 · Cited by 603
Fernández-Ortiz, A., Badimon, J. J., Falk, E., Fuster, V., Meyer, B., Mailhac, A., Weng, D., Shah, P. K., & Badimon, L. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90657-2 · Cited by 587
Fourcade, O., Simon, M.-F., Viodé, C., Rugani, N., Leballe, F., Ragab, A., Fournié, B., Sarda, L., & Chap, H. (1995) · Cell · doi:10.1016/0092-8674(95)90295-3 · Cited by 536
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model.
Han, D. K. M., Haudenschild, C. C., Hong, M. K., Tinkle, B. T., Leon, M. B., & Liau, G. (1995) · Europe PMC (PubMed Central) · Cited by 480
Barry, O. P., Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119385 · Cited by 480
Geng, Y.-J., Wu, Q., Muszynski, M., Hansson, G. K., & Libby, P. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.19 · Cited by 434
Björkerud, S., & Björkerud, B. (1996) · Europe PMC (PubMed Central) · Cited by 414
Satta, N., Toti, F., Feugeas, O., Bohbot, A., Dachary-Prigent, J., Eschwège, V, Hedman, H., & Freyssinet, J. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.7.3245 · Cited by 372
Self-citationMoreno, P. R., Bernardi, V. H., Lo´pez-Cue´llar, J., Murcia, A. M., Palacios, I. F., Gold, H. K., Mehran, R., Sharma, S. K., Nemerson, Y., Fuster, V., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3090 · Cited by 356
Aupeix, K., Hugel, B., Martin, T., Bischoff, P., Lill, H., Pasquali, J. L., & Freyssinet, J. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119317 · Cited by 274
Self-citationIdentification of Active Tissue Factor in Human Coronary Atheroma
Marmur, J. D., Thiruvikraman, S. V., Fyfe, B. S., Guha, A., Sharma, S. K., Ambrose, J. A., Fallon, J. T., Nemerson, Y., & Taubman, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1226 · Cited by 254
Annex, B. H., Denning, S. M., Channon, K., Sketch, M. H., Stack, R. S., & Peters, K. G. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)93041-a · Cited by 254
Bach, R., Gentry, R., & Nemerson, Y. (1986) · Biochemistry · doi:10.1021/bi00362a005 · Cited by 253
Dong, Z., Saikumar, P., Weinberg, J. M., & Venkatachalam, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 233
Tissue-factor antigen and activity in human coronary atherosclerotic plaques
Ardissino, D., Merlini, P. A., Ariëns, R., Coppola, R., Bramucci, E., & Mannucci, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11189-2 · Cited by 228
Kockx, M. M., Muhring, J., Knaapen, M., & Meyer, G. R. Y. D. (1998) · Europe PMC (PubMed Central) · Cited by 226
The Composition of Coronary-Artery Plaques
Davies, M. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361809 · Cited by 220
Rosenfeld, M. E., Khoo, J. C., Miller, E., Parthasarathy, S., Palinski, W., & Witztum, J. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115006 · Cited by 215
Thiruvikraman, S. V., Guha, A., Roboz, J., Taubman, M. B., Nemerson, Y., & Fallon, J. T. (1996) · PubMed · Cited by 184
Thrombin Generation by Apoptotic Vascular Smooth Muscle Cells
Flynn, P. D., Byrne, C. D., Baglin, T. P., Weissberg, P. L., & Bennett, M. R. (1997) · Blood · doi:10.1182/blood.v89.12.4378 · Cited by 143
The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions
Cai, W.-J., Devaux, B., Schaper, W. K. A., & Schaper, J. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06099-1 · Cited by 138
Bennett, M. R., Littlewood, T. D., Schwartz, S. M., & Weissberg, P. L. (1997) · Circulation Research · doi:10.1161/01.res.81.4.591 · Cited by 132
Satta, N., Freyssinet, J., & Toti, F. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2059.x · Cited by 86
Self-citationColocalization of CPP-32 With Apoptotic Cells in Human Atherosclerotic Plaques
Mallat, Z., Ohan, J., Lesèche, G., & Tedgui, A. (1997) · Circulation · doi:10.1161/01.cir.96.2.424 · Cited by 86
Self-citationBlood Cell Membranes and Haemostasis
Zwaal, R. F. A., & Hemker, H. C. (2009) · Haemostasis · doi:10.1159/000214638 · Cited by 74
Oyxsterols induce membrane procoagulant activity in monocytic THP-1 cells
Aupeix, K., Toti, F., Satta, N., Bischoff, P. L., & Freyssinet, J. (1996) · Biochemical Journal · doi:10.1042/bj3141027 · Cited by 45
Self-citationThe immunological potential of apoptotic debris produced by tumor cells and during HIV infection
Kornbluth, R. S. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)00149-9 · Cited by 38
Cited by
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Self-citationExtracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Metadata
- Authors
- Mallat, Z., Hugel, B., Ohan, J., Lesèche, G., Freyssinet, J.-M., & Tedgui, A.
- Venue
- Circulation
- Published
- 1999-01-26
- Volume
- 99
- Issue
- 3
- Pages
- 348-353
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2163431279
- Cited by
- 638
- References
- 37
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.